期刊文献+

非瓣膜性房颤缺血性卒中患者临床特征分析 被引量:5

The clinical characteristic analysis of ischemic stroke in patients with non-valvular atrial fibrillation
下载PDF
导出
摘要 目的对非瓣膜性心房颤动合并缺血性卒中患者进行临床特征分析,为缺血性卒中防治提供临床依据。方法 198例缺血性卒中患者按有无心房颤动分为合并组(71例)与非合并组(127例);比较2组临床特征及相关生化指标,并使用CHADS2与CHA2DS2-VASc评分系统对合并房颤组患者进行危险分层,寻找合并心房颤动缺血性卒中的相关危险因素并进行分析。结果合并组年龄、住院时间、高血压史、心率、同型半胱氨酸(Hcy)高于非合并组;总胆固醇(TC)、三酰甘油(TG)及极低密度脂蛋白胆固醇(VLDL-C)均低于非合并组(P<0.05)。合并组CHA2DS2-VASc评分均处于中高危水平。高龄、较快心率为非瓣膜性房颤缺血性脑卒中的独立危险因素。ROC曲线示年龄(AUC=0.761,临界值=72.50岁)及心率(AUC=0.612,临界值=76.50次/min)对非瓣膜性房颤缺血性卒中均具有预测诊断价值。年龄的敏感度(70.4%)和特异度(71.1%)最高,最佳临界值为72.5岁。结论非瓣膜性房颤缺血性卒中患者临床特征为较高年龄、较快的心率、较高CHA2DS2-VASc评分以及较高的Hcy水平。 Objective To analyze the clinical and laboratory characteristics of the ischemic stroke in patients withnon-valvular atrial fibrillation(AF), and to provide evidence for the prevention of ischemic stroke. Methods A total of 198 patients with ischemic stroke were chosen and divided into two groups: with AF(71 patients)/ and without AF(127 patients)groups. Clinical data and biochemical markers were collected and compared in two groups. CHADS2 and CHA2DS2-VAScscore systems were used to determine the risk levels in patients with AF. Finally, related risk factors of ischemic stroke withAF were determined and analyzed. Results The values of age, length of hospital stay, the hypertention history, heart rateand plasma homocysteine(Hcy) were significantly higher in the with-AF group than those in the without-AF group(P 0.05). The levels of total cholesterol(TC), triglyceride(TG) and very low density lipoprotein cholesterol(VLDL-C) were sig-nificantly lower in the with-AF group than those of the without-AF group(P 0.05). CHA2DS2-VASc scores reached to themoderate-to-high risk level in the with-AF group. Multiple-factor logistic regression analysis showed that age and heart ratewere the independent risk factors of the ischemic stroke in patients with non-valvular AF. ROC analysis indicated that age(AUC=0.761, cut-off point=72.50 years old) and heart rate(AUC=0.612, cut-off point =76.50 bit/min) had predictive and di-agnostic value for the ischemic stroke in patients with non-valvular AF. The age of these patients had the best sensitivity(70.4%) and specifity(71.1%), and the cut-off point of which was 72.50 years old. Conclusion The characteristics of isch-emic stroke in patients with non-valvular AF includes older age, faster heart rate, higher CHA2DS2-VASc scores and higherHcy level.
出处 《天津医药》 CAS 2016年第4期474-477,共4页 Tianjin Medical Journal
基金 天津市卫计委中医 中西医结合科研课题(2015068)
关键词 心房颤动 卒中 脑缺血 年龄 心率 早期诊断 CHA2DS2-VASc评分 同型半胱氨酸 危险因素 非瓣膜性心房颤动 atrial fibrillation stroke brain ischemia age heart rate early diagnosis CHA2DS2-VASc score homocysteine risk factor non-valvular atrial fibrillation
  • 相关文献

参考文献2

二级参考文献99

  • 1Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282. 被引量:1
  • 2Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005. 被引量:1
  • 3Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442. 被引量:1
  • 4Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213. 被引量:1
  • 5Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7. 被引量:1
  • 6Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312. 被引量:1
  • 7Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617. 被引量:1
  • 8Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439. 被引量:1
  • 9Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032. 被引量:1
  • 10Kwiatkowski TG, Libman RB, Fmnkel M, et al. Effects of tissue plasrrfinogen activator for acute ischemic stroke at one year. National Institute of Neurological Disordeis and Stroke Recombinxaat Tissue Plasmiogen Activator Stroke Study Group. N Engl J Med, 1999, 340: 1781-1787. 被引量:1

共引文献1351

同被引文献78

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部